Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

The outcome of composite bone graft substitute used to treat cavitary bone defects.

Siegel HJ, Baird RC 3rd, Hall J, Lopez-Ben R, Lander PH.

Orthopedics. 2008 Aug;31(8):754.

PMID:
19292421
2.
3.
4.
5.

Beta-tricalcium phosphate as a synthetic cancellous bone graft in veterinary orthopaedics: a retrospective study of 13 clinical cases.

Franch J, Díaz-Bertrana C, Lafuente P, Fontecha P, Durall I.

Vet Comp Orthop Traumatol. 2006;19(4):196-204.

PMID:
17143391
6.

Ultraporous β-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial.

Damron TA, Lisle J, Craig T, Wade M, Silbert W, Cohen H.

J Bone Joint Surg Am. 2013 Jan 16;95(2):158-66. doi: 10.2106/JBJS.K.00181.

PMID:
23324964
7.

Applications of calcium phosphate-based cancellous bone void fillers in trauma surgery.

Szpalski M, Gunzburg R.

Orthopedics. 2002 May;25(5 Suppl):s601-9. Review.

PMID:
12038849
8.

Ultraporous beta-tricalcium phosphate is well incorporated in small cavitary defects.

Anker CJ, Holdridge SP, Baird B, Cohen H, Damron TA.

Clin Orthop Relat Res. 2005 May;(434):251-7.

PMID:
15864061
9.

The role of the osteoconductive scaffold in synthetic bone graft.

Vaccaro AR.

Orthopedics. 2002 May;25(5 Suppl):s571-8. Erratum in: Orthopedics 2002 Nov;25(11):1224.

PMID:
12038844
10.

[A novel therapeutic approach to bone replacement: vitalisation of industrial processed allogenic bone graft with autologous bone marrow].

Schmid U, Thielemann F, Weise K, Ochs BG.

Z Orthop Unfall. 2007 Mar-Apr;145(2):221-9. German.

PMID:
17492564
11.

Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.

Van Hoff C, Samora JB, Griesser MJ, Crist MK, Scharschmidt TJ, Mayerson JL.

Am J Orthop (Belle Mead NJ). 2012 Jan;41(1):20-3.

PMID:
22389890
12.

A histomorphogenic analysis of bone grafts augmented with adult stem cells.

Smiler D, Soltan M, Lee JW.

Implant Dent. 2007 Mar;16(1):42-53.

PMID:
17356371
13.

[Clinical results and the mechanism of bone healing for the repair of bone defects due to tumor resection with novel interporous TCP].

Sang H, Wang Z, Guo Z, Wang L, Li J, Meng G, Li X, Lu J.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Apr;22(4):463-7. Chinese.

PMID:
18575450
14.

Biphasic ceramic bone substitute mixed with autogenous bone marrow in the treatment of cavitary benign bone lesions.

El-Adl G, Mostafa MF, Enan A, Ashraf M.

Acta Orthop Belg. 2009 Feb;75(1):110-8.

PMID:
19358408
15.

[Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material].

Zhang P, Gan YK, Tang J, Hao YQ, Wang Y, Sun YH, Zhu ZA, Dai KR.

Zhonghua Wai Ke Za Zhi. 2008 Apr 1;46(7):493-6. Chinese.

PMID:
18785556
16.

Pediatric cranial vault defects: early experience with beta-tricalcium phosphate bone graft substitute.

Biskup NI, Singh DJ, Beals S, Joganic EF, Manwaring K.

J Craniofac Surg. 2010 Mar;21(2):358-62. doi: 10.1097/SCS.0b013e3181cf606b.

PMID:
20186087
17.

Use of 3D beta-tricalcium phosphate (Vitoss) scaffolds in repairing bone defects.

Damron TA.

Nanomedicine (Lond). 2007 Dec;2(6):763-75. Review.

PMID:
18095844
18.

Evaluation of a novel biphasic calcium phosphate in standardized bone defects: a histologic and histomorphometric study in the mandibles of minipigs.

Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D.

Clin Oral Implants Res. 2007 Dec;18(6):752-60. Epub 2007 Sep 20.

PMID:
17888014
19.

The use of bone-graft substitutes in large bone defects: any specific needs?

Calori GM, Mazza E, Colombo M, Ripamonti C.

Injury. 2011 Sep;42 Suppl 2:S56-63. doi: 10.1016/j.injury.2011.06.011. Epub 2011 Jul 12. Review.

PMID:
21752369
20.

Bone marrow/allograft component therapy. A clinical trial.

Skoff HD.

Am J Orthop (Belle Mead NJ). 1995 Jan;24(1):40-7.

PMID:
7773655

Supplemental Content

Support Center